Postischemic sevoflurane offers no additional neuroprotective benefit to preischemic dexmedetomidine

Journal of Neurosurgical Anesthesiology

Volumn 25, Issue 2, 2013, Pages 184-190

  Jeon, Young Tae ^a   Hwang, Jung Won ^a   Lim, Young Jin ^a   Park, Seon Kyoung ^a   Park, Hee Pyoung ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

apoptosis; cerebral ischemia; dexmedetomidine; neuroprotection; sevoflurane postconditioning

Indexed keywords

DEXMEDETOMIDINE; PROTEIN BAX; PROTEIN BCL 2; SEVOFLURANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAROTID ARTERY OBSTRUCTION; CELL VIABILITY; CONDITIONING; CONTROLLED STUDY; DISEASE MODEL; HEMORRHAGIC HYPOTENSION; HIPPOCAMPAL CA1 REGION; HISTOPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE; TRANSIENT ISCHEMIC ATTACK;

ACTINS; ANESTHETICS, INHALATION; ANIMALS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; BRAIN; DEXMEDETOMIDINE; HEMOGLOBINS; HYPNOTICS AND SEDATIVES; IN SITU NICK-END LABELING; ISCHEMIC ATTACK, TRANSIENT; ISCHEMIC PRECONDITIONING; METHYL ETHERS; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TISSUE EMBEDDING;

EID: 84875046723     PISSN: 08984921     EISSN: 15371921     Source Type: Journal    
DOI: 10.1097/ANA.0b013e3182764d2a     Document Type: Article

References (30)

1. Schifilliti D, Grasso G, Conti A, et al. Anaesthetic-related neuroprotection: intravenous or inhalational agents? CNS Drugs. 2010;24:893-907
2. Sato K, Kimura T, Nishikawa T, et al. Neuroprotective effects of a combination of dexmedetomidine and hypothermia after incomplete cerebral ischemia in rats. Acta Anaesthesiol Scand. 2010;54:377-382
3. Dahmani S, Rouelle D, Gressens P, et al. Characterization of the postconditioning effect of dexmedetomidine in mouse organotypic hippocampal slice cultures exposed to oxygen and glucose deprivation. Anesthesiology. 2010;112:373-383
4. Goyagi T, Nishikawa T, Tobe Y, et al. The combined neuroprotective effects of lidocaine and dexmedetomidine after transient forebrain ischemia in rats. Acta Anaesthesiol Scand. 2009;53: 1176-1183
5. Cosar M, Eser O, Fidan H, et al. The neuroprotective effect of dexmedetomidine in the hippocampus of rabbits after subarachnoid hemorrhage. Surg Neurol. 2009;71:54-59; discussion 59
6. Tanabe K, Takai S, Matsushima-Nishiwaki R, et al. Alpha2 adrenoreceptor agonist regulates protein kinase C-induced heat shock protein 27 phosphorylation in C6 glioma cells. J Neurochem. 2008;106:519-528
7. Eser O, Fidan H, Sahin O, et al. The influence of dexmedetomidine on ischemic rat hippocampus. Brain Res. 2008;1218:250-256
8. Talke P, Bickler PE. Effects of dexmedetomidine on hypoxia-evoked glutamate release and glutamate receptor activity in hippocampal slices. Anesthesiology. 1996;85:551-557
9. Huang R, Chen Y, Yu AC, et al. Dexmedetomidine-induced stimulation of glutamine oxidation in astrocytes: a possible mechanism for its neuroprotective activity. J Cereb Blood Flow Metab. 2000;20:895-898
10. Engelhard K, Werner C, Eberspacher E, et al. The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg. 2003;96:524-531
11. Ye Z, Huang YM, Wang E, et al. Sevoflurane-induced delayed neuroprotection involves mitoK(ATP) channel opening and PKC epsilon activation. Mol Biol Rep. 2012;39:5049-5057
12. Yang Q, Dong H, Deng J, et al. Sevoflurane preconditioning induces neuroprotection through reactive oxygen species-mediated up-regulation of antioxidant enzymes in rats. Anesth Analg. 2011;112:931-937
13. Lin D, Li G, Zuo Z. Volatile anesthetic post-treatment induces protection via inhibition of glycogen synthase kinase 3beta in human neuron-like cells. Neuroscience. 2011;179:73-79
14. Wang JK, Yu LN, Zhang FJ, et al. Postconditioning with sevoflurane protects against focal cerebral ischemia and reperfusion injury via PI3K/Akt pathway. Brain Res. 2010;1357:142-151
15. Adamczyk S, Robin E, Simerabet M, et al. Sevoflurane pre- and post-conditioning protect the brain via the mitochondrial K ATP channel. Br J Anaesth. 2010;104:191-200
16. Nito C, Kamiya T, Ueda M, et al. Mild hypothermia enhances the neuroprotective effects of FK506 and expands its therapeutic window following transient focal ischemia in rats. Brain Res. 2004;1008:179-185
17. Scholler K, Zausinger S, Baethmann A, et al. Neuroprotection in ischemic stroke- combination drug therapy and mild hypothermia in a rat model of permanent focal cerebral ischemia. Brain Res. 2004;1023:272-278
18. Thoresen M, Hobbs CE, Wood T, et al. Cooling combined with immediate or delayed xenon inhalation provides equivalent longterm neuroprotection after neonatal hypoxia-ischemia. J Cereb Blood Flow Metab. 2009;29:707-714
19. Smith ML, Bendek G, Dahlgren N, et al. Models for studying longterm recovery following forebrain ischemia in the rat. 2. A 2-vessel occlusion model. Acta Neurol Scand. 1984;69:385-401
20. Matchett GA, Allard MW, Martin RD, et al. Neuroprotective effect of volatile anesthetic agents: molecular mechanisms. Neurol Res. 2009;31:128-134
21. Janke LE, Samra S. Dexmedetomidine and neuroprotection. Semin Anesth Perioperative Med Pain. 2006;25:71-76
22. Zhang Y, Zhang FG, Meng C, et al. Inhibition of sevoflurane postconditioning against cerebral ischemia reperfusion-induced oxidative injury in rats. Molecules. 2012;17:341-354
23. Pape M, Engelhard K, Eberspacher E, et al. The long-term effect of sevoflurane on neuronal cell damage and expression of apoptotic factors after cerebral ischemia and reperfusion in rats. Anesth Analg. 2006;103:173-179
24. Matsumoto M, Zornow MH, Rabin BC, et al. The alpha 2
25. adrenergic agonist, dexmedetomidine, selectively attenuates ischemia- induced increases in striatal norepinephrine concentrations. Brain Res. 1993;627:325-329
26. Jolkkonen J, Puurunen K, Koistinaho J, et al. Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia. Eur J Pharmacol. 1999;372:31-36
27. Engelhard K, Werner C, Kaspar S, et al. Effect of the alpha2- agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats. Anesthesiology. 2002;96: 450-457
28. Dahmani S, Rouelle D, Gressens P, et al. Effects of dexmedetomidine on hippocampal focal adhesion kinase tyrosine phosphorylation in physiologic and ischemic conditions. Anesthesiology. 2005;103:969-977
29. Hoffman WE, Kochs E, Werner C, et al. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole. Anesthesiology. 1991;75:328-332
30. Ozden S, Isenmann S. Neuroprotective properties of different anesthetics on axotomized rat retinal ganglion cells in vivo. J Neurotrauma. 2004;21:73-82